
You can purchase shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) through any online brokerage.
There are no as such competitors for ProShares UltraShort Nasdaq Biotechnology.
There is no analysis for ProShares UltraShort Nasdaq Biotechnology to provide a consensus price target.
The stock price for ProShares UltraShort Nasdaq Biotechnology (NASDAQ: BIS) is $12.2 last updated October 16, 2026 at 6:04 PM EDT.
There are no upcoming dividends for ProShares UltraShort Nasdaq Biotechnology.
ProShares UltraShort Nasdaq Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for ProShares UltraShort Nasdaq Biotechnology.
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and...